Clinical Trial Update: Histoblood Group Antigens as a Risk Factor of Asthma

View source ↗

Summary

A completed UCSF study investigates whether histoblood group antigens are risk factors for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of California, San Francisco | Conditions: Asthma, Lung Diseases | Status: COMPLETED